Skip to main content

Table 2 Summary of primary outcome measures and expected results

From: Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial

Primary outcome Measurement method Estimated outcomes
Placebo Fenofibrate
AAA-wall OPN concentration (pg/mg) ELISA 210 ± 145 84 ± 87
AAA-wall macrophages (per mm2 section) IHC 4.9 ± 1.8 2.4 ± 1.8
Serum OPN concentration (ng/mL) ELISA 77 ± 32 46 ± 32
  1. AAA abdominal aortic aneurysm, ELISA enzyme-linked immunosorbent assay, IHC immunohistochemistry, OPN osteopontin